Infant Bacterial Therapeutics
Eva Idén is on the Board of Directors at Infant Bacterial Therapeutics. She has extensive experience in leading management positions in Astra and AstraZeneca. Currently, she is a consultant in leadership and organizational development and is the business owner of Better & Beyond AB and a partner in Inflecto AB. Eva Idén is also on the board of Better & Beyond AB.
Eva earned her degree in Chemical Engineering from the Chalmers University of Technology.
This person is not in the org chart
This person is not in any offices
Infant Bacterial Therapeutics
IBT is a clinical stage pharmaceutical company with a vision to develop drugs influencing the infant microbiome, and thereby prevent or treat rare diseases affecting infants.